Although intracerebral transplantation might become a new strategy for the treatment of neurological diseases, there are many problems for the grafts, We examined the possibilities of primary skin fibroblasts as a new graft for Parkinson's disease. Rat primary skin fibroblasts were transfected with a retrovirus vector containing eDNA of human tyrosine hydroxylast typel (TH) (pLTHSNL) or cytomegalovirus promoter (pCTHSNL) as a foreign promoter. In these genetically modified fibroblasts, catecholamine production and release were analyzed in vitro by immunocytochemistry and high performance liquid chromatography with electrochemical detection (HPLC-ECD) , Being supplemented with biopterin (BH.; (6R)-L-erythro-tetrahydrobiopterin) cofactors required for TH activity, these cells produced and released L-DOPA into the culture medium. When combined with a foreign promoter and BH., L-DOPA production increased in a timedependent manner, which was not affected by the number of cell-passages and the duration of liquid nitrogen freezing . These facts suggest that the amount of L-DOPA secreted from transplanted genetically modified fibroblasts can be manipulated by an inserted promoter the exogenously administered BH.. Thus genetically modified primary skin fibroblasts transfected with THcDNA using retrovirus vector system may hold promise as a graft for transplantation and gene therapy for Parkinson's disease.
Introduction
Intracerebral grafting, e,g. using adrenal medullary and fetal tissue, becomes a useful technique for treatment of central nervous systemic disease (1) (2) . We propose that a combination of gene transfer via efficient virus vectors and intracerebral grafting of genetically modified cells may constitute an effective approach to Parkinson's disease (3) (4) (5) , In the § Author to who m corre spo ndence should be addressed. present study, rat primary skin fibroblasts were transfected with a retrovirus vector containing cDNA for human tyrosine hydroxylase type 1 (TH), These celIs were used to examine the influence of BH. ((6R)-L-erythro-5,6,7,8-tetrahydrobiopterin) and, production and release of L-DOPA in vitro.
Materials and Methods

Fibroblast Preparation
Rat primary fibroblasts were obtained from abPteridines/ VoL 7 / No. 4 dominal skin biopsies of 5-week-old female albino Wistar rats. The cells were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal serum (4, 5) .
Preparation of Retrovirus Vector
Preparation of the vectors used in the present experiments has been described in a previous paper (5) . LTHSNL was drived from the Moloney murine leukemia virus and expressed the fulllength human TH typel cDNA from 5' long terminal repeat (LTR) and CTHSNL expressed cDNA from the cytomegarovirus promoter (CMV) (Fig. 1) . Plasmid DNA containing the DGL, LTHSNL and LCTHSNL provirus were transfected by the calcium phosphate method (Chen-Okayama's method) into an amphotropic packaging cell line GP+E86. Each culture medium from these cells infected rat primary fibroblasts in the presence of Polybrene (6 J..lg/ ml).
Immunocytochemistry
Normal rat fibroblasts (NRF), fibroblasts transfected DGL (RF/V) , LTHSNL (RF/LT) and CTHSNL (RF/CT) underwent the first TH immunocytochemical staining after 5-passages with TH antiserum. The second staining was performed after 10-passages after preservation for 10 months in liquid nitrogen (5) .
Measurement of L-DOPA Production and Release
The production and release of L-DOPA from NRF, RF/V, RF/LT and RF/CT with or without 1 mM BIL were measured using high-perf or- mance liquid chromatography with electrochemical detection (HPLC-ECD). In the series of experiments, each typed cell was cultured in 3 ml DMEM with 10% fetal serum at a cell density of 1 x 10 6 /ml and incubated with or without 1 ruM BH. for 1, 2, 3, 6, 12, and 24 hr at 37°C. Then L-DOPA levels in the medium were measured by HPLC-ECD.
Results and Discussion
RF /LT and RF /CT immunocytochemically stained with TH antiserum without being affected by the number of cell-passages or freezing (Fig.  2) , but NRF and RF/V did not stain whatsoever. When supplemented in vitro with 1 mM BH., a precursor of the required TH cofactor, only RF/ LT and RF/CT produced and released LDOPA in the culture medium (Table 1) . L-DOPA production increased ill time-dependent manner when combined with foreign promoters CMV and BH. (RF/CT) (Fig. 3) . This character was not affected by the number of cell passages or period of freezing in liquid nitrogen (Table 1 , Figs. 2-3 ) . This indicates that foreign gene (THc-DNA) containing retrovirus vector integrates into the chromosomal DNA of the target cells (6) . These findings suggest that primary fibroblasts genetically altered to express. TH have the capacity to deliver L-DOPA stably in the brain. Also L-DOPA production can be manipulated through a foreign promotor and exogenously administered BH 4 • We propose that combination gene transfer with virus vector and intracerebral grafting could be an effective strategy for the treatment of hyman neurological disease and has specific implication for Parkinson 's diseases.
